| 1 | 17-Hydroxypregnenolone | 24 Hrs Urine |
| 2 | 17-OHP [17-Hydroxyprogesterone] | Serum |
| 3 | 5-HIAA [5-Hydroxyindole Acetic Acid] | 24 Hrs Urine |
| 4 | ACE [Angiotensin Converting Enzyme] Level | Serum |
| 5 | ACHR [Acetylcholine Receptor] Antibodies, Quantitative | Serum |
| 6 | ACTH [Adrenocorticotropic Hormone] | Serum |
| 7 | Activated Protein C Resistance, PCR | Plasma [Sodium Citrate] |
| 8 | Activated Protein C Resistance, PCR | Whole Blood [EDTA] |
| 9 | Adenovirus | |
| 10 | ADH [Anti-diuretic Hormone] [Vasopressin] | Plasma [EDTA] & Serum |
| 11 | AFB Smear | Body fluid |
| 12 | AFB Smear | Sputum |
| 13 | AFP [Alpha Fetoprotein] | Serum |
| 14 | Albumin | Serum |
| 15 | Aldolase | Serum |
| 16 | Aldosterone level | 24 Hrs Urine |
| 17 | Aldosterone level [Supine] | Serum |
| 18 | Aldosterone level [Up right] | Serum |
| 19 | Aldosterone/Renin Ratio (Supine) [ARR] | |
| 20 | Aldosterone/Renin Ratio (Up right) [ARR] | |
| 21 | Alkaline Phosphatase Iso-enzymes | Serum |
| 22 | Allergy, Food Panel [30 Allergens] | Serum |
| 23 | Allergy, Paediatric Panel [30 Allergens] | Serum |
| 24 | Allergy, Respiratory Panel [30 Allergens] | Serum |
| 25 | ALP [Alkaline Phosphatase] | Serum |
| 26 | Alpha Thalassemia Trait | Whole Blood [EDTA] |
| 27 | ALT [Alanine Aminotransferase] [GPT] | Serum |
| 28 | AMA [Anti Mitochondrial Antibody] | Serum |
| 29 | AMH [Anti Mullerian Hormone] | Serum |
| 30 | Amylase | 24 Hrs Urine |
| 31 | Amylase | Spot Urine |
| 32 | Amylase | Body Fluid |
| 33 | Amylase | Serum |
| 34 | ANA [Anti-Nuclear Antibody] | Serum |
| 35 | ANA Latex | Serum |
| 36 | ANA- Profile (All Profiles) | Serum |
| 37 | ANA- Profile: | Serum |
| AIH [Autoimmune Hepatitis] [LKM1 Abs, LC1 Abs, SLA Abs, F-actin Abs] | |
| 38 | ANA- Profile: | Serum |
| Autoimmune Gastritis [IF (intrinsic factor), PCA (Parietal Cell Antibodies)] | |
| 39 | ANA- Profile: | Serum |
| Celiac Disease [Anti-gliadin Abs, Anti-tTG Abs] | |
| 40 | ANA- Profile: | Serum |
| Goodpasture syndrome [GBM (Glomerular Basement Membrane)] | |
| 41 | ANA- Profile: | Serum |
| Milk intolerance [ß-Lactoglobulin Abs] | |
| 42 | ANA- Profile: | Serum |
| PBC [Primary Biliary Cirrhosis] [M2 Abs, M2/PDC-E2, M2/BCO ADC-E2, M2/OGDC-E2, gp210, sp100] | |
| 43 | ANA- Profile: | Serum |
| Polymyositis/Dermatomyositis and Scleroderma [Jo-1 Abs, PL-7 & PL-12 Abs, EJ, OJ, KS, HA, ZO, SRP Abs, MDA-5 Abs, Anti-TIF1-l Abs, Mi-2 Abs, HMGCR Abs, SAE Abs, NXP-2 Abs, PM-Scl Abs, Ku Abs, Scl-70 Abs, RNA polymerase III Abs, Th/To, Anti-Fibrillarin Abs, NOR-90] | |
| 44 | ANA- Profile: | Serum |
| Sharp Syndrome [RNP Abs, Sm/RNP Abs] | |
| 45 | ANA- Profile: | Serum |
| Sjogrens Syndrome [Anti-SSA, TRIM21, SSB Abs] | |
| 46 | ANA- Profile: | Serum |
| SLE [Systemic Lupus Erythromatosus] [ds-DNA Abs, Histone Protein, Nucleosome Abs, Sm Abs, Ribosome P protein (RPP) Abs, PCNA, Centromere Abs] | |
| 47 | ANA- Profile: | Serum |
| Vasculitis syndrome [Proteinase 3 (RP3), Myeloperoxidase MPO, C-ANCA, P-ANCA] | |
| 48 | ANCA/PR3 [Antineutrophil Cytoplasmic Antibodies] | Serum |
| 49 | Androgen | Serum |
| 50 | Androstenedione | Serum |
| 51 | Anti- Chlamydia Antibodies, IgA | Serum |
| 52 | Anti- Chlamydia Antibodies, IgG | Serum |
| 53 | Anti- Chlamydia Antibodies, IgM | Serum |
| 54 | Anti-Cardiolipin Antibodies, IgG | Serum |
| 55 | Anti-Cardiolipin Antibodies, IgM | Serum |
| 56 | Anti-Endomysial Antibodies, IgA | Serum |
| 57 | Anti-Endomysial Antibodies, IgG | Serum |
| 58 | Anti-GAD [Glutamic Acid Decarboxylase Abs] [GADA] | Serum |
| 59 | Anti-HBc Ab [Hepatitis B Core Antibodies, IgM] | Serum |
| 60 | Anti-HBc Ab [Hepatitis B Core Antibodies, Total] | Serum |
| 61 | Anti-HBe Ab [Hepatitis B Envelope Antibodies] | Serum |
| 62 | Anti-HBs Ab [Hepatitis B Surface Antibody] titer | Serum |
| 63 | Anti-Insulin Antibodies | Serum |
| 64 | Anti-Intrinsic factor | Serum |
| 65 | Anti-La [Anti-SS-B Antibody] | Serum |
| 66 | Anti-Ro [Anti-SS-A Antibody] | Serum |
| 67 | Anti-Sm [Anti-Smith Antibodies] | Serum |
| 68 | Anti-Sperm Antibody | Serum |
| 69 | Anti-TG [Anti Thyroglobulin Antibodies] | Serum |
| 70 | Anti-Thrombin III | Plasma [Sodium Citrate] |
| 71 | Anti-TPO [Anti Thyroid Peroxidase Antibodies] | Serum |
| 72 | APCA [Anti Parietal Cell Antibodies] | Serum |
| 73 | aPTT [Activated Partial Thromboplastin Time] | Plasma [Sodium Citrate] |
| 74 | ASMA [Anti Smooth Muscle Abs] | Serum |
| 75 | ASO [Anti-Streptolysin O] | Serum |
| 76 | ASO [Anti-Streptolysin O] titer | Serum |
| 77 | AST [Aspartate Aminotransferase] [GOT] | Serum |
| 78 | BCR/ABL Translocation [BCR-ABL fusion-Gene] | Whole Blood [EDTA] |
| 79 | BCR/ABL Translocation [BCR-ABL fusion-Gene] | Whole Blood [Heparin] |
| 80 | Bence-Jones Protein | 24 Hrs Urine |
| 81 | Bence-Jones Protein | Spot Urine |
| 82 | Beta- Globin Gene, Beta- Thalassemia, PCR | Amniotic Fluid |
| 83 | Beta- Globin Gene, Beta- Thalassemia, PCR | Whole Blood [EDTA] |
| 86 | Beta-2 Glycoprotein Antibodies, IgG | Serum |
| 87 | Beta-2 Glycoprotein Antibodies, IgM | Serum |
| 88 | BFFM [Blood Film for Malaria] | Whole Blood [EDTA] |
| 89 | Bilirubin, Direct | Serum |
| 90 | Bilirubin, Indirect | Spot Urine |
| 91 | Bilirubin, Indirect | Serum |
| 92 | BK Virus, PCR Quantitative | |
| 93 | Bleeding Time | |
| 94 | Blood Culture (Identification & Sensitivity) | Whole Blood in Specialized Bottle |
| 95 | Blood Film | Whole Blood [EDTA] |
| 96 | Blood Group and Rh Typing | Whole Blood [EDTA] |
| 97 | Blood PH | Fresh Blood |
| 98 | Body Fluid Analysis [Cell Count & Chemical] | Body Fluid |
| 99 | Brucella Abs Total [2-Mercaptoethanol] [2-ME] | Serum |
| 100 | Brucella Antibodies, IgG | Serum |
| 101 | Brucella Antibodies, IgM | Serum |
| 102 | BUN [Blood Urea Nitrogen] | Serum |
| 103 | C3 [Complement 3] | Serum |
| 104 | C4 [Complement 4] | 1 ml Serum |
| 105 | CA 125 [Cancer Antigen 125] | Serum |
| 106 | CA 15-3 [Cancer Antigen 15-3] | Serum |
| 107 | CA 19-9 [Cancer Antigen 19-9] | Serum |
| 108 | CA 27-29 [Cancer Antigen 27-29] | Serum |
| 109 | Calcitonin | Serum |
| 110 | Calcium | 24 Hrs Urine |
| 111 | Calcium | Spot Urine |
| 112 | Calcium Total | Serum |
| 113 | Calcium, Ionised | Serum |
| 114 | Calcium/Creatinine | |
| 115 | Calprotectin | Stool |
| 116 | Catecholamines, Adrenaline [Epinephrine] | Plasma [EDTA] |
| 117 | Catecholamines, Adrenaline [Epinephrine] | 24 Hrs Urine |
| 118 | Catecholamines, Metanephrines | Plasma [EDTA] |
| 119 | Catecholamines, Metanephrines | 24 hrs Urine |
| 120 | Catecholamines, Noradrenaline [Norepinephrine] | Plasma [EDTA] |
| 121 | Catecholamines, Noradrenaline [Norepinephrine] | 24 Hrs Urine |
| 122 | Catecholamines, Normetanephrine | |
| 123 | Catecholamines, Normetanephrine | |
| 124 | Catecholamines, Total | 24 Hrs Urine |
| 126 | CBC [Complete Blood Count] | Whole Blood [EDTA] |
| 127 | CBP [Complete Blood Picture] | Whole Blood [EDTA] |
| 128 | CCP-Ab [Cyclic Citrullinated Peptide Antibodies] | Serum |
| 129 | CEA [Carcinoembryonic Antigen] | Serum |
| 131 | Cerebrospinal Fluid Analysis [Cell Count & Chemical] | CSF |
| 132 | Ceruloplasmin | Serum |
| 133 | CH50 [Complement Haemolytic Activity-50] | Serum |
| 134 | Chloride | Serum |
| 135 | Chloride | 24 Hrs Urine |
| 136 | Chloride | Spot Urine |
| 137 | Cholesterol, Total | Serum |
| 138 | Chromosomal analysis for Down syndrome | |
| 139 | Chromosomal Analysis for female abortion | |
| 140 | Chromosomal Karyotyping | Amniotic Fluid |
| 141 | Chromosomal Karyotyping | Chorrionic Villus Sample |
| 142 | Chromosomal Karyotyping, Fragile X Syndrome | Whole Blood [Heparin] |
| 143 | Chromosomal Karyotyping, Peripheral Blood | Whole Blood [Heparin] |
| 144 | Chromosomal Karyotyping, Products of Conception Abortus | |
| 145 | Citrate | 24 Hrs Urine |
| 146 | CK-MB [Creatine Kinase MB] | Serum |
| 147 | Clotting time | |
| 148 | CMV [Anti-Cytomegalovirus Antibody, IgG] | Serum |
| 149 | CMV [Anti-Cytomegalovirus Antibody, IgM] | Serum |
| 150 | CMV Qualitative, PCR | |
| 151 | CMV Quantitative, PCR | |
| 152 | Coombs Test, Direct [Anti-globulin] Test | Whole Blood [EDTA] |
| 153 | Coombs Test, Indirect (IAGT) | Serum |
| 154 | Copper | Serum |
| 155 | Copper | 24 Hrs Urine |
| 156 | Cortisol (Evening 4-8 pm) | Serum |
| 157 | Cortisol (Morning 7-10 am) | Serum |
| 158 | Cortisol, Free (24 Hour) | 24 Hrs Urine |
| 159 | Cortisol, Total | Spot Urine |
| 160 | Cortisol, Total (24 Hour) | 24 Hrs Urine |
| 161 | Cortisol, Total [Evening, Morning] | Serum |
| 162 | C-Peptide | Serum |
| 163 | CPK [Creatine Phosphokinase] | Serum |
| 164 | Creatine kinase | Serum |
| 165 | Creatinine | 24 Hrs Urine |
| 166 | Creatinine | Spot Urine |
| 167 | Creatinine | Serum |
| 168 | Creatinine clearance (CrCl) | 24 Hrs Urine & Serum |
| 169 | Cross Match | Whole Blood [EDTA] & Serum (Donor and Patient) |
| 170 | CRP [C-Reactive Protein] | Serum |
| 171 | CRP [C-Reactive Protein] Latex | Serum |
| 172 | CRP Ultrasensitive Latex | Serum |
| 173 | CSF for Culture and Sensitivity | CSF |
| 174 | Culture For Deep Wound | Swab |
| 175 | Cyclosporine (C0) | Whole Blood [EDTA] |
| 176 | Cyclosporine (C2) | Whole Blood [EDTA] |
| 177 | Cystic Fibrosis, PCR | Amniotic Fluid |
| 178 | Cystic Fibrosis, PCR | Whole Blood [EDTA] |
| 179 | Cystine, Qualitative | 24 Hrs Urine |
| 180 | Cytomegalovirus DNA , PCR Quantitative | Plasma [EDTA] |
| 181 | D-Dimer | Plasma [Sodium Citrate] |
| 182 | Dexamethasone Suppression test | Serum |
| 183 | DHEA-S [Dehydroepiandrosterone Sulphate] | Serum |
| 184 | DNA Analysis for TB (Tuberculosis), PCR | Urine |
| 185 | ds-DNA Abs, IgG (Anti-Double Strand DNA) | Serum |
| 186 | ds-DNA Abs, IgM (Anti-Double Strand DNA) | Serum |
| 187 | Ear Swab for Culture and Sensitivity | Swab |
| 188 | EBV [Epstein Barr Virus], PCR | Whole Blood [EDTA] |
| 189 | Echinococcus Antibody, IgG | Serum |
| 190 | Echovirus Antibody, IgG | Serum |
| 191 | EII [E2][Estradiol] | Serum |
| 192 | Electrolyte with Calcium (Ionized, Free) | |
| 193 | Electrolytes (Na, K, Cl) | Serum |
| 194 | Electrolytes (Na, K, Cl) | 24 hours Urine |
| 195 | Electrolytes (Na, K, Cl) | Spot Urine |
| 196 | ENA (Extractable Nuclear Antigens Antibodies, Full Panel) | Serum |
| 197 | EPO [Erythropoietin] | Serum |
| 198 | ESR [Erythrocyte Sedimentation Rate] | Sodium Citrate |
| 199 | Estriol, Free | Serum |
| 200 | Extended metabolic newborn screen | 4 Blood Drops on Card |
| 201 | Factor II | Plasma [Sodium Citrate] |
| 202 | Factor II or Prothrombine gene | Plasma [Sodium Citrate] |
| 203 | Factor II Prothrombin A Mutation, PCR | Whole Blood [EDTA] |
| 204 | Factor IX | |
| 205 | Factor IX | Plasma [Sodium Citrate] |
| 206 | Factor V | |
| 207 | Factor V | Plasma [Sodium Citrate] |
| 208 | Factor V Leiden | |
| 209 | Factor V R2 (H1299R) | |
| 210 | Factor VI | |
| 211 | Factor VII | |
| 212 | Factor VII | Plasma [Sodium Citrate] |
| 213 | Factor VIII | Plasma [Sodium Citrate] |
| 214 | Factor X | Plasma [Sodium Citrate] |
| 215 | Factor XI | Plasma [Sodium Citrate] |
| 216 | Factor XII | Plasma [Sodium Citrate] |
| 217 | Factor XIII | Plasma [Sodium Citrate] |
| 218 | Fasciola hepatice IgG | Serum |
| 219 | FDP [Fibrinogen Degradation Product] | Plasma [Sodium Citrate] |
| 220 | Ferritin | Serum |
| 221 | Fibrinogen | Plasma [Sodium Citrate] |
| 222 | Trisomy 13 | Whole Blood [EDTA] |
| 223 | Trisomy 13 | Amniotic Fluid |
| 224 | Trisomy 13, 18 | Whole Blood [EDTA] |
| 225 | Trisomy 13, 18 | Amniotic Fluid |
| 226 | Trisomy 13, 18 ,21 | Amniotic Fluid, Whole Blood [EDTA], Whole Blood [Heparin], CVS |
| 227 | Trisomy 18 | Whole Blood [EDTA] |
| 228 | Trisomy 18 | Amniotic Fluid |
| 229 | Trisomy 21 | Amniotic Fluid |
| 230 | Trisomy 21 | Whole Blood [EDTA] |
| 231 | Trisomy X, Y | Whole Blood [EDTA] |
| 232 | Trisomy X, Y | Amniotic Fluid |
| 233 | Trisomy X, Y, 21 | Whole Blood [EDTA] |
| 234 | Trisomy X, Y, 21 | Amniotic Fluid |
| 235 | Trisomy X, Y, 21, 13, 18 | Whole Blood [EDTA] |
| 236 | Trisomy X, Y, 21, 13, 18 | Amniotic Fluid |
| 238 | FMF Gene Mutation [Familial Mediterranean Fever], PCR | Whole Blood [EDTA] |
| 239 | FOB [Fecal Occult Blood] | Stool |
| 240 | Folate [Folic Acid] | Serum |
| 241 | Free PSA/Total PSA ratio | Serum |
| 242 | FSH [Follicle Stimulating Hormone] | Serum |
| 243 | F-T3 [Triiodothyronin, Free] | Serum |
| 244 | F-T4 [Thyroxine, Free] | Serum |
| 245 | G6PD [Glucose-6-Phosphate Dehydrogenase] | Whole Blood [EDTA] |
| 246 | GBM [Glomerular Basement Membrane Abs] | Serum |
| 247 | General Microscopy Examination | Sample Dependant |
| 248 | General Stool Examination | Stool |
| 249 | General Urine Examination | Urine |
| 250 | Gentamicin | Serum |
| 251 | GGT [Gamma Glutamyl Transferase] | Serum |
| 252 | GH [Growth Hormone], After Stimulation, Exercise | Serum |
| 253 | GH [Growth Hormone], Basal Level | Serum |
| 254 | Gliadin IgA | Serum |
| 255 | Gliadin IgG | Serum |
| 256 | Globulin | Serum |
| 257 | Glucose | Urine |
| 258 | Glucose | Body Fluid |
| 259 | Glucose | CSF |
| 260 | Glucose [Fasting] [Random] | Serum |
| 261 | Gram Stain | CSF or Swab |
| 262 | GTT [Glucose Tolerance Test] | Serum at Each Time Point |
| 263 | H.V.S for Culture and Sensitivities | Swab |
| 264 | Haemoglobin Electrophoresis, [HPLC] | Whole Blood [EDTA] |
| 265 | Hb [Haemoglobin] | Whole Blood [EDTA] |
| 266 | HbA1c [Haemoglobin A1c] [Glycosylated] | Whole Blood [EDTA] |
| 267 | HBe Ag [Hepatitis B Envelope Antigen] | Serum |
| 268 | HbH inclusion body | Whole Blood [EDTA] |
| 269 | HBs Ag [Hepatitis Bs Ag] | Serum |
| 270 | HBV [Hepatitis B Virus], PCR Quantitative | Serum |
| 271 | HCV Ab [Hepatitis C Virus Abs] | Serum |
| 274 | HDL [High Density Lipoprotein] | Serum |
| 275 | HDL [High Density Lipoprotein] | Serum |
| 276 | Helicobacter pylori Abs, IgA | Serum |
| 277 | Helicobacter pylori Abs, IgG | Serum |
| 278 | Helicobacter Pylori Ag | Stool |
| 279 | HAV [Hepatitis A Virus] Abs, IgM | Serum |
| 280 | HAV [Hepatitis A Virus] Abs, Total | Serum |
| 281 | HCV [Hepatitis C Virus] Genotyping, PCR | Serum |
| 282 | HCV [Hepatitis C Virus], PCR Quantitative | Serum |
| 283 | HSV I & II [Herpes Simplex Virus I & II] Abs, IgG | Serum |
| 284 | HSV I & II [Herpes Simplex Virus I & II] Abs, IgM | Serum |
| 285 | HEV [Hepatitis E virus], PCR | |
| 286 | H-FABP [Heart-fatty acid binding protein] | Serum |
| 287 | HIV I & II Abs | Serum |
| 288 | HLA 29 Typing | |
| 289 | HLA- ABC Tissue Typing | Whole Blood [EDTA] |
| 290 | HLA ABC-DR | Whole Blood [EDTA] |
| 291 | HLA ABDR (B7,B29,DR2,DR4) | Whole Blood [EDTA] |
| 292 | HLA B12 | Whole Blood [EDTA] |
| 293 | HLA- B27 | Whole Blood [EDTA] |
| 294 | HLA- B5 | Whole Blood [EDTA] |
| 295 | HLA B51,52 | Whole Blood [EDTA] |
| 296 | HLA class II DR | Whole Blood [EDTA] |
| 297 | HLA DQ2,8 | Whole Blood [EDTA] |
| 298 | HLA- DR Tissue Typing | Whole Blood [EDTA] |
| 299 | HLA lower level | Whole Blood [EDTA] |
| 300 | HLA Profiles (27-29-50-51-52-5-9-7-17-19) | Whole Blood [EDTA] |
| 301 | HLA Matching | Whole Blood [EDTA] |
| 302 | HLA ABC-DR,DQ | Whole Blood [EDTA] |
| 303 | HLA-DQ | Whole Blood [EDTA] |
| 304 | Homocysteine | Serum |
| 305 | HPV [Human Papillomavirus] Genotyping, PCR | Swab |
| 306 | HSV I & II [Herpes Simplex Virus I & II], PCR | |
| 307 | iFOB Test (FIT) | Stool |
| 308 | IGF-1 [Insulin-like Growth Factor-1] | Serum |
| 309 | IGF-PB3 (Insulin-like Growth Factor -1 Binding Protein 3) | Serum |
| 310 | IGRA for TB | Special Tube |
| 311 | IGRA for TB 1 IGRA for TB 2 | Special Tube |
| 312 | IL-6 [Interleukin-6] | Serum |
| 313 | Immunofexation Test | |
| 314 | IgA [Immunoglobulin A] | CSF |
| 315 | IgA [Immunoglobulin A] | Serum |
| 316 | IgE [Immunoglobulin E] | Serum |
| 317 | IgG [Immunoglobulin G] | Serum |
| 318 | IgG [Immunoglobulin G] | CSF |
| 319 | IgM [Immunoglobulin M] | Serum |
| 320 | IgM [Immunoglobulin M] | CSF |
| 321 | Inhibin A | Serum |
| 322 | Insulin | Serum |
| 323 | Insulin Tolerance Test, Per Sample | Serum at Each Time Point |
| 324 | Intrinsic Factor Blocking Abs | Serum |
| 325 | Iron | Serum |
| 327 | JAK2 Mutation ( V617F/G1849T ) | Whole Blood [EDTA] |
| 328 | Karyotype for sex chromosoms | |
| 329 | Lactate | Serum |
| 330 | Lactate | CSF |
| 331 | Lactose Tolerace Test | Serum at Each Time Point |
| 332 | Lambda Light Chain | 24 Hrs Urine |
| 333 | Lambda Light Chain | Serum |
| 334 | LDH [Lactate Dehydrogenase] | Serum |
| 335 | LDL [Low Density Lipoprotein] | Serum |
| 336 | Lead | Urine |
| 337 | LH [Luteinizing Hormone] | Serum |
| 338 | Lipase | Serum |
| 339 | Lithium | Serum |
| 340 | Liver Antigen Profile [LKM, SLA, M2, LC-1] | Serum |
| 341 | LKM Abs ( Liver Kidney Microsome ) | Serum |
| 342 | LP-PLA2 [Lipoprotein-Associated phospholipase A2] | Plasma [Sodium Citrate] |
| 343 | Lupus Anticoagulant | Plasma [Sodium Citrate] |
| 344 | Magnesium | Serum |
| 345 | Magnesium | 24 Hrs Urine |
| 347 | Microalbumin | 24 Hrs Urine |
| Microalbumin | Spot Urine |
| 348 | Microalbumin -Creatinine Ratio | 24 Hrs Urine |
| 349 | Mid Urine for Culture and Sensitivities | Urine |
| 350 | Milk for Culture and Sensitivities | Urine |
| 351 | Mitochondrial Abs (M2) | Serum |
| 352 | Monospot Test [Infectious Mononucleosis] | Serum |
| 353 | MTHFR (A1298C) | Whole Blood [EDTA] |
| 354 | MTHFR C677T Gene Mutation, PCR | Whole Blood [EDTA] |
| 355 | MTHFR Profile | Whole Blood [EDTA] |
| 356 | Mycobacterium Tuberculosis DNA, PCR | Body Fluids or Urine |
| 357 | MYO [Myoglobin] | Serum |
| 358 | Myoglobin, Quantitative | Spot Urine |
| 359 | Nasal Smear for Eosinophils | Nasal Fluid |
| 360 | NBT [Nitro Blue test] | Serum |
| 361 | Neonatal Screening Profile (1): TSH, G6PD, 17-OHP, IRT, Galactose, Haemoglobinopathies, Amino Acids, Fatty Acids, Organic Acids (45 Disorders ) | 4 Blood Drops on Card |
| 362 | NT-pro B-type Natriuretic Peptide [B-Type Natriuretic Peptide] [BNP] | Serum |
| 363 | Osmolality | Serum |
| 364 | Osmolality | Urine |
| 365 | Osmolality | 24 Hrs Urine Collection |
| 366 | Oxalate | 24 Hrs Urine Collection |
| 367 | Packed Cell Volume PCV | Whole Blood [EDTA] |
| 368 | PANCA/MPO | Serum |
| 369 | Pancreatic Langerhans Islet Cell Abs, IgG [Anti-Islet Cell Abs] | Serum |
| 370 | PAPP-a test (Pregnancy associated plasma protein-A) | Serum |
| 371 | Parvovirus (B-19) Abs, IgG | 1 ml Serum |
| 372 | PCT [Procalcitonin] | Serum |
| 373 | PCV% [Hematocrit](HCT) | Whole Blood [EDTA] |
| 374 | Periphral Blood Smear | Whole Blood [EDTA] |
| 375 | Philadelphia Chromosome, PCR | Whole Blood [EDTA] |
| 376 | Phospholipid Abs, IgG | Serum |
| 377 | Phospholipid Abs, IgM | Serum |
| 378 | Phosphorus | 24 Hrs Urine or Spot Urine |
| 379 | Phosphorus | Serum |
| 381 | Platelet Count | Whole Blood [EDTA] |
| 382 | PML-RarX | |
| 383 | Post Prandial Glucose [After 2 Hours] | Serum |
| 384 | Potassium | 24 Hrs Urine or Spot Urine |
| 385 | Potassium | Body Fluid |
| 386 | Potassium | Serum |
| 387 | Prenatal Interpretive (Down Syndrome) Open NTD & Trisomy 18 (First Trimester Screen) (PAPPA+FBHCG) | Serum |
| 388 | Progesterone | Serum |
| 389 | Pro-Insulin | Serum |
| 390 | Proinsulin (2 hr. Glucose admn.) | Serum |
| 391 | Proinsulin (30 min. Glucose admn.) | Serum |
| 392 | Prolactin | Serum |
| 393 | Protein C Assay | Plasma [Sodium Citrate] |
| 394 | Protein Electrophoresis | Serum |
| 395 | Protein Electrophoresis | Urine |
| 396 | Protein in body fluid | |
| 397 | Protein in C.S.F | |
| 398 | Protein S [Free] | Plasma [Sodium Citrate] |
| 399 | Protein S Assay | Plasma [Sodium Citrate] |
| 400 | Proteinase 3 Abs | Serum |
| 401 | Prothrombin G20210A Mutation, PCR | Whole Blood [EDTA] |
| 402 | Prothrombin gene mutation (Factor II) | |
| 403 | PSA [Prostatic-Specific Antigen], Free | Serum |
| 404 | PSA [Prostatic-Specific Antigen], Total | Serum |
| 405 | PT [Prothrombin Time][INR] | Plasma [Sodium Citrate] |
| 406 | PTH [Parathyroid Hormone] | Serum |
| 407 | PTT [Partial Thromboplastin Time] | Plasma [Sodium Citrate] |
| 408 | PUS for Culture and sensitivities | |
| 409 | Reducing substance | Urine or Stool |
| 410 | Renin ( Healthy donors supine position ) | Plasma [EDTA] |
| 411 | Renin ( Healthy donors up right position ) | Plasma [EDTA] |
| 412 | Renin Activity | Plasma [EDTA] |
| 413 | Reticulocyte Count | Whole Blood [EDTA] |
| 414 | Rheumatiod Factor Abs, IgA | Serum |
| 415 | Rheumatoid Factor | Synovial Fluid |
| 416 | Rheumatoid Factor Abs, IgG | Serum |
| 417 | Rheumatoid Factor Abs, IgM | Serum |
| 418 | Rose Bengal test | Serum |
| 420 | Rotavirus, Ag | Stool |
| 421 | RPR [Rapid Plasma Reagin] [Syphilis] | Serum |
| 422 | Rubella Abs, IgG | Serum |
| 423 | Rubella Abs, IgM | Serum |
| 424 | Semen fructose test | Seminal Fluid |
| 425 | Seminal Fluid Analysis | Seminal Fluid |
| 426 | Seminal for culture and Sensitivities | Seminal Fluid |
| 427 | SHBG [Sex Hormone Binding Globulin] | Serum |
| 428 | SLA [Soluble Liver Antigen] | Serum |
| 429 | Sodium | 24 Hrs Urine or Spot Urine |
| 430 | Sodium | Serum |
| 431 | Sodium | Body Fluids |
| 432 | Spot Urine Albumin | Spot Urine |
| 433 | Spot Urine Creatinine | Spot Urine |
| 434 | Spot Urine Protein | Spot Urine |
| 436 | Sputum for Culture and Sensitivities | Sputum |
| 437 | Sputum for TB | Sputum |
| 438 | ß-hCG | Urine |
| 439 | ß-hCG [Human Chorionic Gonadotropin, ß-Subunit] | Serum |
| 440 | Stone Analysis [Urinary Calculi analysis] | Renal Stone |
| 441 | Swab for Culture and Sensitivities | |
| 442 | Synovial Fluid Analysis | Synovial Fluid |
| 443 | T3-Free (Triiodothyronin, Free) | Serum |
| 444 | T4-Free (Thyroxine, Free) | Serum |
| 445 | Tacrolimus [Prograf] | Whole Blood [EDTA] |
| 446 | Testosterone, Free | Serum |
| 447 | Testosterone, Total | Serum |
| 448 | TG [Thyroglobulin] | Serum |
| 449 | Thrombin Abs | Plasma [Sodium Citrate] |
| 450 | Thrombin Time | Plasma [Sodium Citrate] |
| 451 | TIBC [Total Iron Binding Capacity] | Serum |
| 453 | Total Protein | Serum |
| 454 | Total Protein | Synovial Fluid |
| 455 | Total Protein | 24 Hrs Urine or Spot Urine |
| 456 | Total Protein | Body Fluid |
| 457 | Total Protein | CSF |
| 458 | Toxoplasma gondii Abs, IgG | Serum |
| 459 | Toxoplasma gondii Abs, IgM | Serum |
| 460 | TPHA (Treponema pallidum Hemagglutination)(Syphilis) | Serum |
| 461 | TRAB [Thyroid Stimulating Hormone Receptor Abs] | Serum |
| 462 | Transferrin | Serum |
| 463 | Transferrin Saturation ( TS% ) | Serum |
| 464 | Triglycerides | Serum |
| 465 | Troponin I | Serum |
| 466 | Troponin T | Whole Blood [Heparin] |
| 467 | TSB [Bilirubin, Total] | Serum |
| 468 | TSH [Thyroid Stimulating Hormone] | Serum |
| 469 | tTg Ab, IgA [Tissue Transglutaminase Ab, IgA] | Serum |
| 470 | tTg Ab, IgG [Tissue Transglutaminase Ab, IgG] | Serum |
| 471 | Tuberklin test | |
| 472 | Tyrosine | Plasma [EDTA] |
| 473 | UIBC | Serum |
| 474 | Urea | Serum |
| 475 | Urea | 24 Hrs Urine or Spot Urine |
| 476 | Urea Breath Test | |
| 477 | Urethral Discharge (Culture & Sensitivity) | Swab |
| 478 | Urethral Discharge (gram stain, GC ,microscopic examination) | Swab |
| 479 | Uric Acid | Serum |
| 480 | Uric Acid | 24 Hrs Urine or Spot Urine |
| 481 | Uric Acid | Synovial Fluid |
| 482 | Uric Acid | body fluid |
| 483 | Uric Acid | CSF |
| 484 | Urinary Albumin Excretion Rate | Urine |
| 485 | Urine Albumin (Direct) | Urine |
| 486 | Urine Albumin/Creatinine Ratio (ACR) | Urine |
| 487 | Urine Calcium (Direct) | Urine |
| 488 | Urine Chloride | Urine |
| 489 | Urine for AFB | Urine |
| 490 | Urine for Culture and Sensitivities | Urine |
| 491 | Urine for GC | Urine |
| 492 | Urine for TB-PCR | Urine |
| 493 | Urine Potassium | Urine |
| 494 | Urine Protein Creatinine ratio (PCR) | Urine |
| 495 | Urine Sodium | Urine |
| 496 | Vanilmandelic Acid (VMA) | 24 Hrs Urine |
| 497 | Varicella zoster Virus Abs, IgG VZV | Serum |
| 498 | Varicella zoster Virus Abs, IgM VZV | Serum |
| 499 | Vasopressin (Antidiuretic Hormone) | Plasma [EDTA] & Serum |
| 500 | VCA [EBV][Epstein Barr Virus Capsid Antigens Antibodies, IgG | Serum |
| 501 | VCA [EBV][Epstein Barr Virus Capsid Antigens Antibodies, IgM] | Serum |
| 502 | VDRL [Syphilis] | Serum |
| 503 | Vitamin B12 | Serum |
| 504 | Vitamin D (1,25-Dihydroxycholecalciferol) | Serum |
| 505 | Vitamin D3 (25-Hydroxycholecalciferol) | Serum |
| 506 | VLDL [Very Low Density Lipoprotein] | Serum |
| 507 | VMA [Vanilmandelic Acid] | 24 Hrs Urine |
| 508 | VWF [Von Willibrand][Factor VIII Related Ag] | Plasma [Sodium Citrate] |
| 509 | WBC Differential Count | Whole Blood [EDTA] |
| 510 | White Blood Cell Count (Leucocyte count ) | Whole Blood [EDTA] |
| 511 | Widal Test (Salmonella typhi IgG/IgM) | Serum |
| 512 | Wound for Culture and Sensitivities | Swab |
| 513 | Y- Chromosome Microdeletion, PCR | Whole Blood [EDTA] |
| 514 | Zinc | Serum |
| 515 | Zinc | 24 Hrs Urine |
